The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s anti-asthmatics and COPD drugs market report forecasts the anti-asthmatics and COPD drugs market size to grow to $117.36 Billion by 2027, with a CAGR (compound annual growth rate) of more than 5%.

Learn More On The Anti-Asthmatics And COPD Drugs Market Report 2023 – https://www.thebusinessresearchcompany.com/report/anti-asthmatics-and-copd-drugs-global-market-report

Anti-Asthmatics And COPD Drugs Market Size Forecast
The global anti-asthmatics and COPD drugs market is expected to grow from $88.20 billion in 2022 to $94.10 billion in 2023 at a compound annual growth rate (CAGR) of 6.7%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global anti-asthmatics and COPD drugs market size is expected to grow to $117.36 billion in 2027 at a CAGR of 5.7%.

North America held the largest anti-asthmatics and COPD drugs market share, and Middle East was the fastest-growing region in 2022.

Key Anti-Asthmatics And COPD Drugs Market Driver ­– Increase In Modifiable Risk Factors
For instance, the number of tobacco smokers is set to increase by 24 million in Indonesia and by 7 million in Nigeria by 2025, and more than 40% of global cigarette consumption is concentrated in China. Consumption of fats including saturated fatty acids which is a risk factor for Asthma and COPD is more in high-income countries including the USA and Europe. According to WHO, in developed countries, more than 35% of total energy requirement is derived from fats when compared to <20% in low-income countries, and <25% in lower-middle-income countries.

Request for A Sample Of The Global Anti-Asthmatics And COPD Drugs Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3802&type=smp

Key Anti-Asthmatics And COPD Drugs Market Trend – Adopting Combination Drugs For The Treatment Of Asthma And COPD
This is due to the greater impact on patient-reported outcomes (PROs) compared to monotherapies. For example, a combination of short-acting beta-agonists (SABA) and short-acting muscarinic antagonists (SAMA) is superior compared to either medication alone in improving lung function. The use of a combination of long-acting beta-agonists (LABA), and long-acting muscarinic antagonists (LAMA) have improved lung function than long-acting monotherapy bronchodilators.

Anti-Asthmatics And COPD Drugs Market Segment
1) By Type: Anti-histamine Drugs, long-acting ß2-agonists (LABA), Inhaled corticosteriods, Short-acting muscarinic receptor antagonists (SAMAs), Other Anti-Asthmatics And COPD Drugs (including Combinations)
2) By Drug Class: Bronchodilators, Anti-inflammatory Drugs, Monoclonal Antibodies, Combination Drugs
3) By End User: Asthma Patients, COPD Patients
4) By Distribution Channel: Hospital Pharmacies, Private Clinics, Drug Stores, Retail Pharmacies, E-Commerce

Anti-Asthmatics And COPD Drugs Market Major Players and Strategies
Major players in the anti-asthmatics and COPD drugs market are Novartis AG, Merck & Co., GlaxoSmithKline, Boehringer Ingelheim Gmbh, AstraZeneca, Roche, Teva Pharmaceutical, Vectura, Pfizer and Abbott.

The Anti-Asthmatics And COPD Drugs Global Market Report 2023 covers regional data on anti-asthmatics and COPD drugs market size, anti-asthmatics and COPD drugs market trends and drivers, opportunities, strategies, and anti-asthmatics and COPD drugs market competitor analysis. The countries covered in the anti-asthmatics and COPD drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Anti-asthmatic and chronic obstructive pulmonary disease refers to drugs that are used to relieve the frequency of acute attacks of asthma, emphysema, chronic bronchitis, and nocturnal awakenings.

View More Reports Related To The Anti-Asthmatics And COPD Drugs Market –
Anti-Hypertensive Drugs Global Market Report 2023
Anti-virals Global Market Report 2023
Drugs For Erectile Dysfunction Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: